| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ACURA PHARMACEUTICALS, INC | Director | Common Stock | 1.96M | $313K | $0.16 | Jan 2, 2024 | By Essex Woodlands Health Venture Fund V, L.P. |
| ACURA PHARMACEUTICALS, INC | Director | Common Stock | 448K | $71.6K | $0.16 | Jan 2, 2024 | Direct |
| ACURA PHARMACEUTICALS, INC | Director | Restricted Stock Units (2021 Plan) | 50K | $8K | $0.16 | Jan 2, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ACUR | ACURA PHARMACEUTICALS, INC | Jan 2, 2024 | 3 | $0 | 4 | Jan 2, 2024 | Director |
| ACUR | ACURA PHARMACEUTICALS, INC | Jan 3, 2023 | 3 | $0 | 4 | Jan 5, 2023 | Director |
| ACUR | ACURA PHARMACEUTICALS, INC | Jan 3, 2022 | 3 | $0 | 4 | Jan 12, 2022 | Director |
| ACUR | ACURA PHARMACEUTICALS, INC | May 25, 2021 | 1 | $0 | 4 | May 28, 2021 | Director |